Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: a Danish population-based cohort study

J Infect. 2002 Oct;45(3):144-51. doi: 10.1016/s0163-4453(02)91037-6.

Abstract

Objectives: Studies about the efficiency of pre-hospital antibiotic treatment of meningococcal disease are conflicting. We examined the case fatality rate in patients with meningococcal disease treated with pre-hospital antibiotics.

Methods: A cohort study of 534 patients hospitalized with meningococcal disease from two Danish counties. Clinical data were obtained from referral letters from general practitioners and hospital records. Complete follow-up for all patient until death or discharge.

Results: Seventy-seven patients (16% of the patients seen by a general practitioner) received parenteral antibiotics before hospital admission; 9 (12%) of them died. Of 402 patients who did not receive pre-hospital parenteral antibiotics, 26 (7%) died. The overall risk of case fatality among antibiotic-treated patients was increased with adjusted odds ratio (OR) = 2.4 (95% CI, 1.0-5.6). Meningococcus serogroup B was associated with increased case fatality in patients who received pre-hospital parenteral antibiotics (OR = 2.6; 95% CI, 0.8-8.3) in contrast to other serogroups. In Aarhus County there were no deaths in patients who received pre-hospital parenteral antibiotics, but in North Jutland County the case fatality was high (OR = 2.9; 95% CI, 1.2-6.8).

Conclusions: The efficiency of pre-hospital parenteral antibiotic treatment seems to be dependent on hospital care and may vary with the serogroup.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Cohort Studies
  • Community Health Planning
  • Denmark / epidemiology
  • Female
  • Follow-Up Studies
  • Hospitalization
  • Humans
  • Infant
  • Infusions, Parenteral / methods
  • Male
  • Meningococcal Infections / drug therapy*
  • Meningococcal Infections / epidemiology
  • Meningococcal Infections / mortality*
  • Mortality
  • Neisseria meningitidis / pathogenicity
  • Risk Factors
  • Serologic Tests / methods
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents